Industrial and Corporate Change, Volume 11, Number 4, pp. 847-874
© 2002 Oxford University Press
The distinctive patterns of capabilities accumulation and inter-firm heterogeneity: the case of the Spanish pharmaceutical industry
Correspondence: P. D'Este, SPRU, University of Sussex, Mantell Building, Brighton BN1 9RF, UK; prpg1{at}sussex.ac.uk.
Abstract
This paper examines the extent to which systematic differences in performance across firms can be explained by the different sets of capabilities mastered by firms. Cluster analysis is used to group firms based on the degree of capability accumulation along three dimensions: manufacturing, R&D and marketing. Sixty-seven Spanish domestic pharmaceutical firms are studied, focusing on the period 19901997. Our findings indicate that five clusters can be identified. Firms with better performance indicators are those that manage to generate capabilities that are uncommon among competitorsparticularly capabilities in product development.